Healthcare biotechnology is providing patients with more personalized therapies, potentially safer products, and more effective treatments for unmet medical needs. Esperion is focused on developing novel therapies to prevent, treat, and reverse cardiovascular and metabolic diseases. Cardiovascular disease is the number one cause of death among men and women in the U. S. and Esperion seeks to change that. If you suffer from cardiovascular or metabolic diseases, please know that Esperion is working hard and fast to provide your physician with new therapeutic alternatives for your treatment.